LifeMD Balance Sheet Health

Financial Health criteria checks 5/6

LifeMD has a total shareholder equity of $5.6M and total debt of $18.3M, which brings its debt-to-equity ratio to 328%. Its total assets and total liabilities are $58.5M and $52.9M respectively.

Key information

328.0%

Debt to equity ratio

US$18.26m

Debt

Interest coverage ration/a
CashUS$33.15m
EquityUS$5.57m
Total liabilitiesUS$52.91m
Total assetsUS$58.48m

Recent financial health updates

Recent updates

Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Apr 25
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

Mar 30
Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program

Mar 13

LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability

Jan 22

LifeMD: A GLP-1 Play With A Kicker

Jan 11

Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Jan 05
Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Jan 05
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Apr 17
Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

Nov 17
Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

LifeMD launches at-home screening kits for breast, colon cancers

Sep 14

LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M

Aug 11

LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine

Jan 10

LifeMD: 4 Reasons You Should Avoid This Stock

Sep 29

LifeMD: Telehealth Growth Spectacular

Sep 17

LifeMD: 'Actual, Hard Numbers' Keep Us Bullish

Jul 13

Two class-action shareholder suits against LifeMD dropped

May 28

LifeMD (LFMD) Investor Presentation - Slideshow

May 01

Financial Position Analysis

Short Term Liabilities: LFMD's short term assets ($42.6M) exceed its short term liabilities ($34.8M).

Long Term Liabilities: LFMD's short term assets ($42.6M) exceed its long term liabilities ($18.1M).


Debt to Equity History and Analysis

Debt Level: LFMD has more cash than its total debt.

Reducing Debt: LFMD's debt to equity ratio has increased from 30.2% to 328% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable LFMD has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: LFMD is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 37.6% per year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.